Concussion Market is estimated to be valued at USD 7.24 Bn in 2025 and is expected to reach USD 10.96 Bn by 2032, exhibiting a CAGR of 6.1% from 2025 to 2032 ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Analysts have recently evaluated Abbott Laboratories and provided 12-month price targets. The average target is $145.12, ...

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Abbott Laboratories recently experienced a 20% price increase over the last quarter. This uptick coincides with several noteworthy developments, including Abbott's collaboration with Cadrenal ...

Abbott Laboratories (NYSE:ABT – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday after Citigroup raised their price target on the stock from $135.00 to $ ...

But there’s a powerful fundamental story happening with Abbott Laboratories. Also, EPS is estimated to ramp higher this year by +10.8%. Now it makes sense why the stock has been powering to new ...

The project is in its early stages. According to city officials, construction is likely to start in 2027 and it’s expected to ...